Budd‑Chiari syndrome, a rare complication of multicentric Castleman disease: A case report
- Authors:
View Affiliations
Affiliations: Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China, Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China
- Published online on: March 3, 2015 https://doi.org/10.3892/ol.2015.3010
-
Pages:
2153-2156
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
A 39‑year‑old female presented to The First Affiliated Hospital of Jishou University (Jishou, Hunan) with a fever of unknown origin and progressive abdominal distension. Physical examination revealed generalized lymphadenopathy, multiple non‑tender cutaneous nodules, hepatomegaly, splenomegaly and abdominal edema. An axillary lymph node biopsy indicated hyaline vascular type Castleman disease, and color Doppler and computed tomography scans suggested Budd‑Chiari syndrome (BCS). Based on the abdominal distension and impairments of the liver and kidneys, an inferior vena cavography and balloon dilatation were performed, confirming the diagnosis of BCS and leading to symptomatic improvement. The patient commenced a combination chemotherapy regimen of cyclophosphamide (0.4 g; days 1‑3), vindesine (4 mg; day 1) and prednisolone (100 mg; days 1‑5), with no melioration of symptoms. Theprubicin was added to suppress the aggravation of the disease on day six of the chemotherapy cycle. The patient exhibited symptomatic remission for one week, however, she subsequently succumbed to intracranial hemorrhage and infections of the lung and intestine due to long‑term myelosuppression following chemotherapy. To the best of our knowledge, this is the first report of BCS in a patient with multicentric Castleman disease without human immunodeficiency virus infection.
View References
|
1
|
Kojima M, Nakamura N, Tsukamoto N, et al:
Clinical implications of idiopathic multicentric castleman disease
among Japanese: a report of 28 cases. Int J Surg Pathol.
16:391–398. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robinson D Jr, Reynolds M, Casper C, et
al: Clinical epidemiology and treatment patterns of patients with
multicentric Castleman disease: results from two US treatment
centres. Br J Haematol. 165:39–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seo S, Yoo C, Yoon DH, et al: Clinical
features and outcomes in patients with human immunodeficiency
virus-negative, multicentric Castleman's disease: a single medical
center experience. Blood Res. 49:253–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Enomoto K, Nakamichi I, Hamada K, et al:
Unicentric and multicentric Castleman's disease. Br J Radiol.
80:e24–e26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nozari N, Vossoghinia H, Malekzadeh F, et
al: Long-term Outcome of Budd-Chiari Syndrome: A Single Center
Experience. Middle East J Dig Dis. 5:146–150. 2013.PubMed/NCBI
|
|
6
|
Bargalló X, Gilabert R, Nicolau C, et al:
Sonography of Budd-Chiari syndrome. AJR Am J Roentgenol.
187:W33–W41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoekstra J and Janssen HL: Vascular liver
disorders (I): diagnosis, treatment and prognosis of Budd-Chiari
syndrome. Neth J Med. 66:334–339. 2008.PubMed/NCBI
|
|
8
|
Miralles GD, O'Fallon JR and Talley NJ:
Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS
syndrome. N Engl J Med. 327:1919–1923. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chronowski GM, Ha CS, Wilder RB, et al:
Treatment of unicentric and multicentric Castleman disease and the
role of radiotherapy. Cancer. 92:670–676. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Powles T, Stebbing J, Montoto S, et al:
Rituximab as retreatment for rituximab pretreated HIV-associated
multicentric Castleman disease. Blood. 110:4132–4133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi X, Wu F, Ren W, et al: Thrombotic risk
factors in Chinese Budd-Chiari syndrome patients. An observational
study with a systematic review of the literature. Thromb Haemost.
109:878–884. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eren S and Akdağ R: Rare complication of
adrenal neuroblastoma: Budd-Chiari syndrome. Pediatr Int.
45:737–739. 2003. View Article : Google Scholar : PubMed/NCBI
|
